radioisotope therapy: Clinical Trials

6 trials of radioisotope therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn. 4 Phase 2, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Withdrawn 2
Not applicable1Completed 1
Phase 31Completed 1

Follow radioisotope therapy: new trials by email Literature Review of radioisotope therapy trials Research Report on radioisotope therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
iodine I 131 metaiodobenzylguanidine, topotecan hydrochloride, chemotherapy - Neuroblastoma
Phase 2WithdrawnChildren's Cancer and Leukaemia Group2008-07-012013-07-10
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
cisplatin, cytarabine, etoposide - AIDS-related Lymphoma, Adult Non-Hodgkin's Lymphoma
Phase 2WithdrawnAIDS Malignancy Consortium2006-02-012016-02-03
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
cisplatin, fluorouracil, questionnaire administration - Esophageal Cancer, Gastric Cancer
Not applicableCompletedNorth Wales Organisation for Randomised Trials in Health7002004-09-012013-08-07
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
filgrastim, dacarbazine, doxorubicin hydrochloride - Sarcoma
Phase 2CompletedRadiation Therapy Oncology Group1997-02-012014-01-24
Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
filgrastim, monoclonal antibody 3F8, cisplatin - Neuroblastoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center451995-02-012013-07-03
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
carboplatin, cisplatin, cyclophosphamide - Neuroblastoma
Phase 3CompletedChildren's Hospital Medical Center, Cincinnati5001990-07-012013-12-19

Conditions studied

Neuroblastoma (3)  ·  Burkitt Lymphoma (1)  ·  Esophageal Neoplasms (1)  ·  Lymphoma, AIDS-Related (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Large-Cell, Immunoblastic (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Sponsors

AIDS Malignancy Consortium (1)  ·  Children's Cancer and Leukaemia Group (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  North Wales Organisation for Randomised Trials in Health (1)  ·  Radiation Therapy Oncology Group (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Alexandra M. Levine, MD (1)  ·  Anil Tulpule, MD (1)  ·  Frank Berthold, MD (1)  ·  Ken Park, MD (1)  ·  Mark N. Gaze, MD (1)  ·  Nai-Kong V. Cheung, MD, PhD (1)  ·  Ronald H. Blum, MD (1)  ·  William G. Kraybill, MD, FACS (1)

Results publications

PMID 11464889, PMID 12101494, PMID 12932669, PMID 16446334, PMID 20572040, PMID 29681762, PMID 36995690